Literature DB >> 26117320

Epigenetic regulation of Keap1-Nrf2 signaling.

Yue Guo1, Siwang Yu2, Chengyue Zhang1, Ah-Ng Tony Kong3.   

Abstract

The kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2) signaling axis serves as a "master regulator" in response to oxidative/electrophilic stresses and chemical insults through the coordinated induction of a wide array of cytoprotective genes. Therefore, activation of Nrf2 is considered to be an important approach for preventing chronic diseases triggered by stresses and toxins, including cancer. Despite extensive studies suggested that the Keap1-Nrf2 signaling pathway is subject to multiple layers of regulation at the transcriptional, translational, and post-translational levels, the potential epigenetic regulation of Nrf2 and Keap1 has begun to be recognized only in recent years. Epigenetic modifications, heritable alterations in gene expression that occur without changes in the primary DNA sequence, have been reported to be profoundly involved in oxidative stress responses. In this review, we discuss the latest findings regarding the epigenetic regulation of Keap1-Nrf2 signaling by DNA methylation, histone modification, and microRNAs. The crosstalk among these epigenetic modifications in the regulation of Keap1-Nrf2 signaling pathways is also discussed. Studies of the epigenetic modification of Nrf2 and Keap1 have not only enhanced our understanding of this complex cellular defense system but have also provided potential new therapeutic targets for the prevention of certain diseases.
Copyright © 2015.

Entities:  

Keywords:  DNA methylation; Epigenetic; Histone modification; Keap1; MicroRNAs; Nrf2

Mesh:

Substances:

Year:  2015        PMID: 26117320      PMCID: PMC4955581          DOI: 10.1016/j.freeradbiomed.2015.06.013

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  124 in total

1.  MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism.

Authors:  Muhua Yang; Yuan Yao; Gabriel Eades; Yongshu Zhang; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2011-06-03       Impact factor: 4.872

Review 2.  Mechanism and function of oxidative reversal of DNA and RNA methylation.

Authors:  Li Shen; Chun-Xiao Song; Chuan He; Yi Zhang
Journal:  Annu Rev Biochem       Date:  2014       Impact factor: 23.643

3.  Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.

Authors:  Lucia Anna Muscarella; Raffaela Barbano; Vincenzo D'Angelo; Massimiliano Copetti; Michelina Coco; Teresa Balsamo; Annamaria la Torre; Angelo Notarangelo; Michele Troiano; Salvatore Parisi; Nadia Icolaro; Domenico Catapano; Vanna Maria Valori; Fabio Pellegrini; Giuseppe Merla; Massimo Carella; Vito Michele Fazio; Paola Parrella
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

4.  A γ-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation.

Authors:  Ying Huang; Tin Oo Khor; Limin Shu; Constance Lay-Lay Saw; Tien-Yuan Wu; Nanjoo Suh; Chung S Yang; Ah-Ng Tony Kong
Journal:  J Nutr       Date:  2012-03-28       Impact factor: 4.798

5.  Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation.

Authors:  Qing Zhong; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-14       Impact factor: 4.799

6.  Gender matters: estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).

Authors:  Sandra Kalthoff; Anja Winkler; Nicole Freiberg; Michael P Manns; Christian P Strassburg
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

7.  Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.

Authors:  Xiao-Jun Wang; Zheng Sun; Nicole F Villeneuve; Shirley Zhang; Fei Zhao; Yanjie Li; Weimin Chen; Xiaofang Yi; Wenxin Zheng; Georg T Wondrak; Pak Kin Wong; Donna D Zhang
Journal:  Carcinogenesis       Date:  2008-04-15       Impact factor: 4.944

8.  Methylation of the KEAP1 gene promoter region in human colorectal cancer.

Authors:  Naoyuki Hanada; Takenori Takahata; Qiliang Zhou; Xulu Ye; Ruowen Sun; Jugoh Itoh; Atsushi Ishiguro; Hiroshi Kijima; Junsei Mimura; Ken Itoh; Shinsaku Fukuda; Yasuo Saijo
Journal:  BMC Cancer       Date:  2012-02-13       Impact factor: 4.430

9.  Regulation of UGT1A1 and HNF1 transcription factor gene expression by DNA methylation in colon cancer cells.

Authors:  Anne-Sophie Bélanger; Jelena Tojcic; Mario Harvey; Chantal Guillemette
Journal:  BMC Mol Biol       Date:  2010-01-22       Impact factor: 2.946

Review 10.  Understanding the role of NRF2-regulated miRNAs in human malignancies.

Authors:  Niraj M Shah; Stuart A Rushworth; Megan Y Murray; Kristian M Bowles; David J MacEwan
Journal:  Oncotarget       Date:  2013-08
View more
  77 in total

Review 1.  Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models.

Authors:  Jan F Stevens; Johana S Revel; Claudia S Maier
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

Review 2.  Reductive stress in striated muscle cells.

Authors:  Ilaria Bellezza; Francesca Riuzzi; Sara Chiappalupi; Cataldo Arcuri; Ileana Giambanco; Guglielmo Sorci; Rosario Donato
Journal:  Cell Mol Life Sci       Date:  2020-02-18       Impact factor: 9.261

Review 3.  Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.

Authors:  Renu A Kowluru; Manish Mishra
Journal:  Free Radic Biol Med       Date:  2016-12-22       Impact factor: 7.376

4.  Keap1/Nrf2 impairing revised: are we missing the single nucleotide polymorphisms?

Authors:  Lucia Anna Muscarella; Vito Michele Fazio
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

5.  A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.

Authors:  E-J Choi; B-J Jung; S-H Lee; H-S Yoo; E-A Shin; H-J Ko; S Chang; S-Y Kim; S-M Jeon
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

6.  Nrf2/antioxidant pathway mediates β cell self-repair after damage by high-fat diet-induced oxidative stress.

Authors:  Tsehay Abebe; Jana Mahadevan; Lindsey Bogachus; Stephanie Hahn; Michele Black; Elizabeth Oseid; Fumihiko Urano; Vincenzo Cirulli; R Paul Robertson
Journal:  JCI Insight       Date:  2017-12-21

7.  Knockdown of TRIM32 Protects Hippocampal Neurons from Oxygen-Glucose Deprivation-Induced Injury.

Authors:  Liang Wei; Jian-Shui Zhang; Sheng-Feng Ji; Hao Xu; Zhao-Hua Zhao; Li Zhang; Long Pang; Jun-Feng Zhang; Peng-Bo Yang; Hai Ma
Journal:  Neurochem Res       Date:  2019-08-13       Impact factor: 3.996

8.  Nuclear lamins and progerin are dispensable for antioxidant Nrf2 response to arsenic and cadmium.

Authors:  Kazunori Hashimoto; Rima Majumdar; Yoshiaki Tsuji
Journal:  Cell Signal       Date:  2017-02-14       Impact factor: 4.315

Review 9.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 10.  Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker?

Authors:  Raúl Barrera-Rodríguez
Journal:  Biomed Rep       Date:  2018-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.